These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33086872)

  • 1. Novel LCAT (Lecithin:Cholesterol Acyltransferase) Activator DS-8190a Prevents the Progression of Plaque Accumulation in Atherosclerosis Models.
    Sasaki M; Delawary M; Sakurai H; Kobayashi H; Nakao N; Tsuru H; Fukushima Y; Honzumi S; Moriyama S; Wada N; Kaneko T; Yamada K; Terasaka N; Kubota K
    Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):360-376. PubMed ID: 33086872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lecithin:cholesterol acyltransferase, high-density lipoproteins, and atheroprotection in humans.
    Calabresi L; Franceschini G
    Trends Cardiovasc Med; 2010 Feb; 20(2):50-3. PubMed ID: 20656215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
    Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P
    Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AAV8-mediated long-term expression of human LCAT significantly improves lipid profiles in hCETP;Ldlr(+/-) mice.
    Chen Z; Chu D; Castro-Perez JM; Ni W; Zhang A; Krsmanovic ML; Xie D; Shah V; Stout SJ; McLaren DG; Stefanni AC; Lee SH; Roddy TP; Plump AS; Hubbard BK; Vogt TF; Zhou HH
    J Cardiovasc Transl Res; 2011 Dec; 4(6):801-10. PubMed ID: 21822774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lecithin:cholesterol acyltransferase deficiency increases atherosclerosis in the low density lipoprotein receptor and apolipoprotein E knockout mice.
    Furbee JW; Sawyer JK; Parks JS
    J Biol Chem; 2002 Feb; 277(5):3511-9. PubMed ID: 11719520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenoviral expression of human lecithin-cholesterol acyltransferase in nonhuman primates leads to an antiatherogenic lipoprotein phenotype by increasing high-density lipoprotein and lowering low-density lipoprotein.
    Amar MJ; Shamburek RD; Vaisman B; Knapper CL; Foger B; Hoyt RF; Santamarina-Fojo S; Brewer HB; Remaley AT
    Metabolism; 2009 Apr; 58(4):568-75. PubMed ID: 19303980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous Atherosclerosis in Aged LCAT-Deficient Hamsters With Enhanced Oxidative Stress-Brief Report.
    Guo M; Liu Z; Xu Y; Ma P; Huang W; Gao M; Wang Y; Liu G; Xian X
    Arterioscler Thromb Vasc Biol; 2020 Dec; 40(12):2829-2836. PubMed ID: 32998519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma cholesteryl esters provided by lecithin:cholesterol acyltransferase and acyl-coenzyme a:cholesterol acyltransferase 2 have opposite atherosclerotic potential.
    Lee RG; Kelley KL; Sawyer JK; Farese RV; Parks JS; Rudel LL
    Circ Res; 2004 Nov; 95(10):998-1004. PubMed ID: 15486318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review on lecithin:cholesterol acyltransferase deficiency.
    Saeedi R; Li M; Frohlich J
    Clin Biochem; 2015 May; 48(7-8):472-5. PubMed ID: 25172171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular basis for activation of lecithin:cholesterol acyltransferase by a compound that increases HDL cholesterol.
    Manthei KA; Yang SM; Baljinnyam B; Chang L; Glukhova A; Yuan W; Freeman LA; Maloney DJ; Schwendeman A; Remaley AT; Jadhav A; Tesmer JJ
    Elife; 2018 Nov; 7():. PubMed ID: 30479275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Very low levels of HDL cholesterol and atherosclerosis, a variable relationship--a review of LCAT deficiency.
    Savel J; Lafitte M; Pucheu Y; Pradeau V; Tabarin A; Couffinhal T
    Vasc Health Risk Manag; 2012; 8():357-61. PubMed ID: 22701329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of human lecithin cholesterol acyltransferase leads to hyperalphalipoproteinemia in transgenic mice.
    Vaisman BL; Klein HG; Rouis M; Bérard AM; Kindt MR; Talley GD; Meyn SM; Hoyt RF; Marcovina SM; Albers JJ
    J Biol Chem; 1995 May; 270(20):12269-75. PubMed ID: 7744879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lecithin:cholesterol acyltransferase: old friend or foe in atherosclerosis?
    Kunnen S; Van Eck M
    J Lipid Res; 2012 Sep; 53(9):1783-99. PubMed ID: 22566575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small molecule activation of lecithin cholesterol acyltransferase modulates lipoprotein metabolism in mice and hamsters.
    Chen Z; Wang SP; Krsmanovic ML; Castro-Perez J; Gagen K; Mendoza V; Rosa R; Shah V; He T; Stout SJ; Geoghagen NS; Lee SH; McLaren DG; Wang L; Roddy TP; Plump AS; Hubbard BK; Sinz CJ; Johns DG
    Metabolism; 2012 Apr; 61(4):470-81. PubMed ID: 22001333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lecithin cholesterol acyltransferase: an anti- or pro-atherogenic factor?
    Rousset X; Shamburek R; Vaisman B; Amar M; Remaley AT
    Curr Atheroscler Rep; 2011 Jun; 13(3):249-56. PubMed ID: 21331766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic overexpression of human lecithin: cholesterol acyltransferase (LCAT) in mice does not increase aortic cholesterol deposition.
    Furbee JW; Parks JS
    Atherosclerosis; 2002 Nov; 165(1):89-100. PubMed ID: 12208474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein A-I and lecithin:cholesterol acyltransferase transfer induce cholesterol unloading in complex atherosclerotic lesions.
    Van Craeyveld E; Lievens J; Jacobs F; Feng Y; Snoeys J; De Geest B
    Gene Ther; 2009 Jun; 16(6):757-65. PubMed ID: 19242527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of human lecithin:cholesterol acyltransferase in mice offers no protection against diet-induced atherosclerosis.
    Mehlum A; Gjernes E; Solberg LA; Hagve TA; Prydz H
    APMIS; 2000 May; 108(5):336-42. PubMed ID: 10937770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of lecithin:cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis.
    Hoeg JM; Santamarina-Fojo S; Bérard AM; Cornhill JF; Herderick EE; Feldman SH; Haudenschild CC; Vaisman BL; Hoyt RF; Demosky SJ; Kauffman RD; Hazel CM; Marcovina SM; Brewer HB
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11448-53. PubMed ID: 8876155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholesteryl ester transfer protein corrects dysfunctional high density lipoproteins and reduces aortic atherosclerosis in lecithin cholesterol acyltransferase transgenic mice.
    Föger B; Chase M; Amar MJ; Vaisman BL; Shamburek RD; Paigen B; Fruchart-Najib J; Paiz JA; Koch CA; Hoyt RF; Brewer HB; Santamarina-Fojo S
    J Biol Chem; 1999 Dec; 274(52):36912-20. PubMed ID: 10601244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.